Literature DB >> 16681042

HPLC determination of tolperisone in human plasma.

Jung-Woo Bae1, Young-Seo Park, Uy-Dong Sohn, Chang-Sun Myung, Byung-Kwon Ryu, Choon-Gon Jang, Seok-Yong Lee.   

Abstract

A simple high performance liquid chromatographic (HPLC) method was developed for the determination of tolperisone in human plasma. Tolperisone and internal standard (chlorphenesin) were isolated from 1 mL of plasma using 8 mL of dichlormethane. The organic phase was collected and evaporated under nitrogen gas. The residue was then reconstituted with 300 mL aliquot of mobile phase and a 100 mL aliquot was injected onto the C18 reverse-phased column. The mobile phase, 45% methanol containing 1% glacial acetic acid and 0.05% 1-hexanesulfonic acid was run at a flow rate of 1 mL/min. The column effluent was monitored using UV detector at 260 nm. The retention times for tolperisone and the internal standard were approximately 7.1 and 8.4 min, respectively. The standard curve was linear with minimal intra-day and inter-day variability. The quantification limit of tolperisone in human plasma was 10 ng/ mL. The proposed method has been applied to the determination of pharmacokinetic profile of tolperisone in Koreans. The Tmax of tolperisone in Koreans (0.94 +/- 0.42 h) was not significantly differ from that reported in Europeans (0.5-1 h), but the mean half-life in Koreans (1.14 +/- 0.27 h) was shorter than that in Europeans (2.56 +/- 0.2 h). The proposed HPLC method is simple, accurate, reproducible and suitable for pharmacokinetic study of tolperisone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681042     DOI: 10.1007/bf02968581

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  5 in total

1.  Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers.

Authors:  M Pawlowska; M Bogiel; J Duda; E Sieradzki
Journal:  Eur J Clin Pharmacol       Date:  2015-05-09       Impact factor: 2.953

Review 2.  Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.

Authors:  Stefan Quasthoff; Claudia Möckel; Walter Zieglgänsberger; Wolfgang Schreibmayer
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

3.  Chemometrics-Assisted UV Spectrophotometric and RP-HPLC Methods for the Simultaneous Determination of Tolperisone Hydrochloride and Diclofenac Sodium in their Combined Pharmaceutical Formulation.

Authors:  Nikunj Rameshbhai Gohel; Bhavin Kiritbhai Patel; Vijaykumar Kunvarji Parmar
Journal:  Sci Pharm       Date:  2013-07-14

4.  Reversed phase-high performance liquid chromatographic method for simultaneous estimation of tolperisone hydrochloride and etodolac in a combined fixed dose oral formulations.

Authors:  Mit J Patel; R Badmanaban; C N Patel
Journal:  Pharm Methods       Date:  2011-04

5.  Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms.

Authors:  Thummala Veera Raghava Raju; Raja Kumar Seshadri; Srinivas Arutla; Tharlapu Satya Sankarsana Jagan Mohan; Ivaturi Mrutyunjaya Rao; Someswara Rao Nittala
Journal:  Sci Pharm       Date:  2012-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.